Eli Lilly Corp. buy Guggenheim
Start price
05.08.24
/
50%
€706.60
Target price
05.08.25
€806.83
Performance (%)
-6.22%
Price
01.08.25
€658.80
This prediction will end soon
Summary
This prediction is currently active. With a performance of -6.22%, the BUY prediction for Eli Lilly Corp. by Guggenheim is down slightly. A total of €3.85 was paid as dividends for this prediction. This prediction currently runs until 05.08.25. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | -4.811% | -4.811% |
| iShares Core DAX® | -3.352% | -0.947% |
| iShares Nasdaq 100 | -0.740% | 3.167% |
| iShares Nikkei 225® | -1.885% | -0.531% |
| iShares S&P 500 | -0.952% | 2.583% |
Comments by Guggenheim for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Guggenheim from $855.00 to $884.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Stopped prediction by Guggenheim for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€672.80
11.07.25
11.07.25
€806.82
11.07.26
11.07.26
-2.08%
01.08.25
01.08.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€662.90
20.06.25
20.06.25
€813.01
20.06.26
20.06.26
-0.62%
01.08.25
01.08.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€844.20
16.08.24
16.08.24
€935.65
16.08.25
16.08.25
-21.65%
01.08.25
01.08.25